The lower expression of plasminogen (PLG) and higher expression of SERPINE1, which encodes plasminogen activator inhibitor-1 (PAI-1) in NAFLD may be an indicator of the presence of a prothrombotic state in the disease. The gene discussed is PLG; the disease is metabolic dysfunction-associated steatotic liver disease.